Zachary Steinhart, PhD
Assistant Professor
Otolaryngology
School of Medicine

The Steinhart Lab aims to apply CRISPR-based functional genomics and gene editing approaches to understand and engineer antitumor immunity. We are particularly interested in studying the genetic basis of signaling, receiving, and processing in the communication networks between tumor, tumor-associated cells, and antitumor T cells in solid tumor microenvironments.

Show full bio (90 words) Hide full bio

We are developing new technologies to rapidly uncover and study the genes controlling these networks using combinatorial gene perturbation approaches coupled with advanced phenotypic readouts. Importantly, we aim to apply these tools in the most disease and therapeutically relevant human cell types, including primary human T cells, and patient-derived tumor infiltrating lymphocytes (TILs) and tumor cells. Our end goal is to translate discoveries to next-generation adoptive cell therapies and/or leverage druggable target discovery to develop novel therapies to enhance antitumor immunity.

Education & Training

Show all (3) Hide

  • Postdoc Genomic Immunology Gladstone Institutes 2026
  • PhD Pharmaceutical Sciences University of Toronto 2019
  • BSc Life Sciences Queen's University 2012

Websites

Show all (1) Hide

Publications (23)

Top publication keywords:
CRISPR-Cas SystemsWnt3A ProteinCarcinoma, Pancreatic DuctalCell Cycle CheckpointsDishevelled ProteinsOncogene ProteinsCell CommunicationFrizzled ReceptorsWnt ProteinsColorectal NeoplasmsPancreatic NeoplasmsWnt Signaling Pathwaybeta CateninHeparan Sulfate ProteoglycansAntibodies

Show all (18 more) Hide